Feng Wang

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Feng Wang
Publication record
35 papers · 785 citations · H-index 13

PAPERS

Abstract 1855: Targeting DGKA for immuno-oncology therapy: ISM4312A, a novel DGKA inhibitor with robust anti-tumor activity
20230 citationsauthor #4
Oxy210, a Semi-Synthetic Oxysterol, Exerts Anti-Inflammatory Effects in Macrophages via Inhibition of Toll-like Receptor (TLR) 4 and TLR2 Signaling and Modulation of Macrophage Polarization
202215 citationsauthor #1
Intrinsically Fluorescent Anti-Cancer Drugs
202213 citationsauthor #2
Quantifying and Mitigating Motor Phenotypes Induced by Antisense Oligonucleotides in the Central Nervous System
202116 citationsauthor #3
Development and Validation of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and the Immune Microenvironment in Gastric Cancer
202113 citationsauthor #1
Oxysterols: A New Hope for an Effective and Safe Therapy for COVID-19, Another Light at the End of the Tunnel
20210 citationsauthor #2
Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Oxysterol Derivatives In Vitro
202125 citationsauthor #2
Identification the ferroptosis-related gene signature in Gastric cancer based on weighted gene co-expression network analysis (WGCNA)
20211 citationsauthor #1
Oxy210, a novel inhibitor of hedgehog and TGF‐β signalling, ameliorates hepatic fibrosis and hypercholesterolemia in mice
202119 citationsauthor #2
IGF-2 Modi ed by the m6A Demethylation Enzyme ALKBH5 in the Ossi cation of the Ligamentum Flavum
20201 citationsauthor #4
Altering the Solubility of the Antibiotic Candidate Nisin—A Computational Study
202019 citationsauthor #3
RNA therapeutics on the rise
2020214 citationsauthor #1
Effect of pimecrolimus on interleukin-33 level in mice with atopic dermatitis and asthma
20190 citationsauthor #2
BRIDGING BETWEEN PROTEIN DYNAMICS AND EVOLUTION THROUGH SIMULATIONS AND MACHINE LEARNING APPROACHES
20190 citationsauthor #1
miR-544 inhibits the migration and invasion of anaplastic thyroid cancer by targeting Yin Yang-1.
201913 citationsauthor #1
Inhibition of Non-Small Cell Lung Cancer Cells by Oxy210, an Oxysterol-Derivative that Antagonizes TGFβ and Hedgehog Signaling
201916 citationsauthor #2
Inhibition of Hedgehog Signaling in Fibroblasts, Pancreatic, and Lung Tumor Cells by Oxy186, an Oxysterol Analogue with Drug-Like Properties
201919 citationsauthor #1
USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia
201881 citationsauthor #9
Abstract B202: Covalent irreversible usp7 inhibitors for cancer immunotherapy
20181 citationsauthor #3
Abstract B193: Characterization of selective active-site targeted covalent inhibitors of usp7
20180 citationsauthor #1
Abstract 1691: USP7 inhibitors impair Foxp3+ T regulatory cell function and promote antitumor immunity against solid tumors
20170 citationsauthor #4
Inhibition of Pancreatic Cancer Cell‐Induced Paracrine Hedgehog Signaling by Liver X Receptor Agonists and Oxy16, a Naturally Occurring Oxysterol
201712 citationsauthor #1
Abstract 5336: Characterization of selective covalent inhibitors of USP7
20170 citationsauthor #1
Chemical Approaches to Intervening in Ubiquitin Specific Protease 7 (USP7) Function for Oncology and Immune Oncology Therapies.
201740 citationsauthor #3
USP7-Specific Inhibitors Target and Modify the Enzyme's Active Site via Distinct Chemical Mechanisms.
2017100 citationsauthor #3
Active site-targeted covalent irreversible inhibitors of USP7 impair the functions of Foxp3+ T-regulatory cells by promoting ubiquitination of Tip60
201748 citationsauthor #1
Abstract B007: Targeting the ubiquitin signaling system for cancer immunotherapy
20160 citationsauthor #4
Ubiquitin-specific Protease-7 Inhibition Impairs Tip60-dependent Foxp3 + T-regulatory Cell Function and Promotes Antitumor Immunity
2016108 citationsauthor #4
Abstract 559: Small molecule T-reg inhibitors for cancer immunotherapy
20161 citationsauthor #4
Abstract 5432: Discovery and characterization of USP22 inhibitors as novel anti-cancer agents
20151 citationsauthor #1
1‑O‑acetylbritannilactone combined with gemcitabine elicits growth inhibition and apoptosis in A549 human non‑small cell lung cancer cells.
20158 citationsauthor #1
Structural and Functional Characterization of FOXO3a in Transcription and Apoptosis
20120 citationsauthor #1
A Study on Drug Resistance Mechanism of HIV-1 Integrase Mutants by Molecular Modeling*: A Study on Drug Resistance Mechanism of HIV-1 Integrase Mutants by Molecular Modeling*
20091 citationsauthor #1
Structure-based drug mechanism study and inhibitor design targeting tuberculosis
20070 citationsauthor #1
‐ O ‐ acetylbritannilactone combined with gemcitabine elicits growth inhibition and apoptosis in A 549 human non ‐ small cell lung cancer cells
year unknown0 citationsauthor #1

TIMELINE

2007 0 citations

2009 1 citations

2012 0 citations

2015 9 citations

2016 109 citations

2017 200 citations

2018 82 citations

2019 48 citations

2020 234 citations

2021 74 citations

2022 28 citations

2023 0 citations

Unknown 0 citations

Feng Wang

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT